share_log

News Highlights: Top company news of the day

News Highlights: Top company news of the day

新闻要点:公司当天的头条新闻
Dow Jones ·  2022/05/04 11:21

Uber Revenue More Than Doubles

优步收入翻了一番以上

The company's revenue rose to $6.85 billion in its latest quarter, as demand for rides rebounded from last year's downturn due to Covid-19 and food delivery grew despite restaurant reopenings.

该公司最近一个季度的收入增至68.5亿美元,原因是新冠肺炎导致的打车需求从去年的低迷中反弹,尽管餐厅重新开业,但外卖业务仍有所增长。

Marriott Sales Soar on Surging Travel Demand

万豪酒店销售额飙升,旅游需求激增

The company reported an 81% jump in first-quarter sales to $4.2 billion.

该公司报告称,第一季度销售额跃升81%,至42亿美元。

CVS Sales Up 11%, Lifted by Vaccine, Test-Kit Demand

CVS销售额增长11%,受疫苗和检测试剂盒需求提振

CVS logged $76.83 billion in revenue in the first quarter, as consumers scooped up take-home Covid-19 test kits.

由于消费者购买了带回家的新冠肺炎测试套件,CVS在第一季度实现了768.3亿美元的收入。

GrubHub Parent Just Eat Probes Senior Executive Over Misconduct Complaint

GRubHub母公司Just Eat调查高管不当行为投诉

The food-delivery company said it had launched an investigation into its chief operating officer over a complaint about possible personal misconduct at a company event.

这家外卖公司表示,已对其首席运营官展开调查,原因是有人投诉称,该公司可能在一次活动中存在个人不当行为。

Tupperware Stock Tumbles After Guidance Withdrawn

特百惠库存在指导被撤回后暴跌

The company pulls its outlook amid higher costs and other problems, and says its turnaround will take longer than expected

在更高的成本和其他问题下,该公司调高了前景,并表示其扭亏为盈的时间将比预期的更长

Ukraine War, Wordle Help New York Times Draw More Subscribers

乌克兰战争,Wordle帮助《纽约时报》吸引更多订户

The news company's profit dropped 89% on Athletic-related acquisition costs.

由于与体育相关的收购成本,新闻公司的利润下降了89%。

Walgreens Names Heads of Marketing, Merchandising and Product

沃尔格林任命营销、销售和产品主管

The drugstore chain tapped the former marketing chief of Calvin Klein as its new CMO and named two other senior executives to support its expanded healthcare strategy.

这家药店连锁店任命卡尔文·克莱恩(Calvin Klein)前营销主管为新的首席营销官,并任命了另外两名高管,以支持其扩大的医疗战略。

Moderna Revenue Triples on Soaring Vaccine Sales

疫苗销量飙升,Moderna收入翻了两番

The biotechnology company's revenue topped $6 billion in its latest quarter, beating analyst expectations, driven almost entirely by sales of its mRNA-based vaccine.

这家生物技术公司在最近一个季度的收入超过了60亿美元,超出了分析师的预期,这几乎完全是由其基于mRNA的疫苗的销售推动的。

Biogen Faces Tough Rebuild After Ditching Troubled Alzheimer's Drug

生物遗传公司在放弃陷入困境的阿尔茨海默氏症药物后面临艰难重建

The biotech's best prospect is another drug for Alzheimer's now in development, but success is far from assured.

生物技术最有希望的是另一种治疗阿尔茨海默氏症的药物,目前正在研发中,但成功还远未确定。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发